openPR Logo
Press release

Global Liquid Biopsy Market rising CAGR of 23.80%, Increasing Demand, Development, and Geographic Overview Forecast till 2027

04-10-2020 11:57 AM CET | Health & Medicine

Press release from: Data Bridge Market Research

Liquid Biopsy is minimally invasive technology which does not require costly invasive procedures. It enables the doctors to access various diseases and make a decision through blood sample of the patient. It is mainly used for monitoring and diagnostic purpose. Various doctors use it to test the cancer in the blood cells of the patient. It only requires 5 milliliters of blood which means they are much easier to tolerate and this makes the procedure quicker than a surgical biopsy.

Global liquid biopsy market is registering a healthy CAGR of 23.80% in the forecast period of 2019-2026. The report contains data from the base year of 2018 and the historic year of 2017. The rise in the market can be attributed due to advent of various innovations and researches in the field of healthcare to integrate technology, to enable diagnosis and treatment with minimally invasive procedures. Few of the major market competitors currently working in the global liquid biopsy market are Eurofins Scientific, MDxHealth, CareDx Inc., Immucor, Inc., Thermo Fisher Scientific Inc., Menarini Silicon Biosystems, QIAGEN, GUARDANT HEALTH, INC, Exact Sciences Corporation, Myriad Genetics, Inc., LungLife AI, Inc., Bio-Rad Laboratories, Inc., Natera, Inc., Trovagene, Exosome Diagnostics, Illumina, Inc., Genomic Health, Biocept, Inc, RainDance Technologies Inc., BGI and F. Hoffmann-La Roche Ltd among others.

Get Sample Report + All Related Graphs & Charts @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-liquid-biopsy-market

Competitive Analysis:

Liquid biopsy market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of liquid biopsy market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Market Drivers

The rising prevalence of cancer is a key driver for the market
Noninvasive procedures preferences have increased which has propelled the market growth
Government and global health organizations have taken many initiatives which has boosted the market
Personalized Medic one has gained a lot of emphasis which has driven the market growth
There are various technological upgradation and advancements to augment market revenues
There are various players spending on R&D for liquid biopsy is boosting the market growth

Market Restraints

There is a lack awareness in developing and underdeveloped counters which act as a restraint to the market growth
There are various limitations associated with liquid biopsy testing which is hampering the market growth
The low sensitivity and specificity is hindering the market growth

Global Liquid Biopsy Market By Sampling Type (Blood Sampling LB, Urine Sampling LB, Saliva & other tissue fluids sampling LB), Products and Service (Assays Kits, Instruments, Services), Circulating Biomarker (Circulating Tumor Cells, Circulating Tumor DNA (CTDNA), Cell-Free DNA, Extracellular Vesicles (Evs), Other Circulating Biomarkers), Clinical Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring), Application (Cancer Applications, Non-Cancer Applications), End User (Reference Laboratories, Hospitals and Physician Laboratories, Academic and Research Centers, Other End Users), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026

Grab Your Report at an Impressive 30% Discount! Please click Here@ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-liquid-biopsy-market

Segmentation: Global Liquid Biopsy Market

By Sample Type

Blood Sampling LB
Urine Sampling LB
Saliva & other tissue fluids sampling LB

By Products and Services

Assay Kits
Instruments
Services

By Circulating Biomarker

Circulating Tumor Cells
Circulating Tumor DNA (CTDNA)
Cell-Free DNA
Extracellular Vesicles (Evs)
Other Circulating Biomarkers

By Clinical Application

Early Cancer Screening
Therapy Selection
Treatment Monitoring
Recurrence Monitoring

By Application

Cancer Applications
Lung Cancer
Breast Cancer
Colorectal Cancer
Prostate Cancer
Liver Cancer
Other Cancers
Non-Cancer Applications

By End User

Reference Laboratories
Hospitals and Physician Laboratories
Academic and Research Centers
Other End Users

Key Developments in the Market:

In May 2019, Thrive Earlier Detection Corp has successfully complete series funding round and raised USD 110 million. The company has used funds to launch CancerSEEK, a liquid biopsy test to detect multiple cancers early. The funds will help the company to expand its product offerings and an increase improves its customer's experience.
In March 2019, QIAGEN had launched novel liquid biopsy solutions and NGS panels with seamlessly integrated bioinformatics which can support the various innovations and advances in cancer research. The launch will enable the company to focus on customer problems as well as expanding the company product portfolio.

Reasons to Purchase this Report

Current and future of global liquid biopsy market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

All segmentation provided above in this report is represented at country level
All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Liquid Biopsy Market rising CAGR of 23.80%, Increasing Demand, Development, and Geographic Overview Forecast till 2027 here

News-ID: 2006483 • Views: 200

More Releases from Data Bridge Market Research

Photo Rejuvenation Devices Market Report Leading Players are biolitec AG, Candel …
Photo Rejuvenation Devices Market analysis report puts across the idea of high level analysis of major market segments and identification of opportunities. This information not only aids businesses in taking sound and proficient decisions but also helps decide the advertising, promotion, marketing and sales strategy more gainfully. Additionally, estimation of strategic options, suggestions of winning action plans and support to make critical bottom-line decisions is also provided by experienced and
Pharmacogenetic Testing Market Shows Strong Growth by 2026 Leading Players : Son …
Pharmacogenetic Testing Market report covers many business strategies such as new product launches, expansions, agreements, partnerships, joint ventures, acquisitions, and others that help to amplify their footprints in the market. This global market report additionally encompasses predictions utilizing a practical arrangement of suspicions and techniques. Depending on client’s demand, huge amount of business, product and market related information has been brought together via this report that eventually helps businesses create
Automated Cell Cultures Market Research Report Trend to 2026 : Top Companies are …
Automated Cell Cultures Market research report aids accomplish the needs of businesses for which it analyses the market from top to bottom by considering plentiful parameters. A strong research methodology used here consists of data models that include market overview and guide, vendor positioning grid, market time line analysis, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. The Automated Cell
Clinical Trial Imaging Market Size to 2026 : Leading Players are BioTelemetry, I …
Global clinical trial imaging market is segmented into five notable segments which are basis of product & services, modality, application, end user and distribution channel. Clinical Trial Imaging Market is a proficient and comprehensive marketing report that focuses on primary and secondary market drivers, market share, leading segments and geographical analysis. Nowadays, businesses get highly benefited with the different segments covered in the market research report which makes available better market

All 5 Releases


More Releases for Cancer

Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and